DUBLIN, June 10, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/bxpb8b/interventional) has announced the addition of the "Interventional Cardiology & Peripheral Vascular Devices Market (Embolic Protection, Chronic Total Occlusion, Atherectomy, Thrombectomy, IVUS, Angiography Catheters, EVAR Stent Grafts, IVC Filters, Stents, Balloons and Accessories) - Forecasts to 2019" report to their offering.
The interventional cardiology and peripheral vascular devices market is expected to reach $26.72 billion by 2019 from $18.73 billion in 2014, at a CAGR of 7.4%
The global interventional cardiology and peripheral vascular devices market is segmented based on products and geography. Based on products, the market is segmented into angioplasty balloons, angioplasty stents, catheters, EVAR stent grafts, IVC filters, plaque modification devices, hemodynamic flow alteration devices, and accessories.
The angioplasty stents segment accounted for the largest share of the interventional cardiology and peripheral vascular devices market during the forecast period. The large share of this segment is attributed to the rising prevalence of cardiovascular diseases and increasing initiatives by companies for developing new and technologically advanced stents for better clinical outcomes.
Major factors contributing to the growth of the interventional cardiology and peripheral vascular devices market include rising aging population, increasing demand of minimally invasive procedures, rising incidence of cardiovascular diseases, and technological advancements. According to the World Health Organization, in 2012, 17.5 million people died due to CVDs; this figure accounted for 31% of the global deaths in 2012. Furthermore, in the same year, 16 million people aged below 70 years died due to non-communicable diseases; of this, 37% deaths were related to CVDs. Emerging markets in Asia have opened an array of opportunities for the growth of the interventional cardiology and peripheral vascular devices market. However, product failures and barriers to entry for small players are expected to restrain the growth of this market.
Key players in this market include Abbott Laboratories (U.S.), Boston Scientific (U.S.), B. Braun Melsungen AG (Germany), Cordis Corporation (U.S.), C.R. Bard, Inc. (U.S.), Medtronic Inc. (U.S.), Terumo Corporation (Japan), and Volcano Corporation (U.S.).
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Insights
7 Angioplasty Market Size, By Type of Procedure
8 Angioplasty Balloons Market, By Type
9 Angioplasty Stents Market, By Type
10 Catheters Market, By Type
11 Endovascular Aneurysm Repair (EVAR) Stent Grafts Market, By Type
12 Inferior Vena Cava (IVC) Filters Market, By Type
13 Plaque Modification Devices Market, By Type
14 Hemodynamic Flow Alteration Devices Market, By Type
15 Accessories Market, By Type
16 Interventional Cardiology and Peripheral Vascular Devices Market, By Region
17 Competitive Landscape
18 Company Profiles
- Abbott Laboratories
- B. Braun Melsungen AG
- Boston Scientific Corporation
- C.R. Bard
- Cordis Corporation (A Subsidiary of Johnson & Johnson Co.)
- Medtronic, Inc.
- Spectranetics International BV
- St. Jude Medical, Inc.
- Terumo Corporation
- Volcano Corporation
For more information visit http://www.researchandmarkets.com/research/bxpb8b/interventional
Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net
